Jianing S. Fang
Changsha, 410013, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
CT-Derived Body Composition and Early Changes Predict Outcomes of First-Line Chemo-Immunotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma.
Journal: The oncologist
Published: June 20, 2026
Efficacy and prognostic analysis of induction chemoimmunotherapy in unresectable stage Ⅲ non-small cell lung cancer: a single-center retrospective study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 16, 2026
Timing of immune checkpoint inhibitors infusion and prognosis in recurrent/metastatic nasopharyngeal carcinoma: a single-center, retrospective study.
Journal: Cancer immunology, immunotherapy : CII
Published: January 27, 2026
Development of a metabolic subtype classifier for low-grade glioma to guide precision therapy.
Journal: Discover oncology
Published: October 04, 2025
Multi-omics reveals the impact of cancer-associated fibroblasts on the prognosis and treatment response of adult diffuse highest-grade gliomas.
Journal: Heliyon
Published: February 28, 2024
Identifying disulfidptosis subtypes in hepatocellular carcinoma through machine learning and preliminary exploration of its connection with immunotherapy.
Journal: Cancer cell international
Published: December 26, 2023
Construction of the novel immune risk scoring system related to CD8+ T cells in uterine corpus endometrial carcinoma.
Journal: Cancer cell international
Published: February 14, 2023
Molecular subtypes based on centrosome-related genes can predict prognosis and therapeutic responsiveness in patients with low-grade gliomas.
Journal: Frontiers in oncology
Published: February 02, 2023
Construction of a novel molecular typing and scoring system for anoikis distinguishes between different prognostic risks and treatment responsiveness in low-grade glioma.
Journal: Frontiers in immunology
Published: November 22, 2022
Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma.
Journal: Frontiers in immunology
Published: May 27, 2022
The long noncoding RNA KTN1-AS1 promotes bladder cancer tumorigenesis via KTN1 cis-activation and the consequent initiation of Rho GTPase-mediated signaling.
Journal: Clinical science (London, England : 1979)
Published: August 03, 2020
Last Updated: 09/26/2026